Q/C Technologies, Inc. Common Stock (QCLS) Stock Price

QCLSStock

$0.54−90.21%52W

Market Cap$4.41M

P/E—

PEG Ratio—

Div yield—

Beta2.21

QCLS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-95.36%

Price vs S&P 500 (4W)-30.09%

VGM Score43.66

Book Value / Share (Quarterly)$2.33

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-1.17

Price vs S&P 500 (YTD)-98.44%

Gross Margin (TTM)24.73%

Net Profit Margin (TTM)-501.52%

EPS (TTM)$-3.83

10-Day Avg Trading Volume0.23M

EPS Excl Extra (TTM)$-3.83

EPS (Annual)$-6.72

Dividend / Share (Annual)$0.50

ROI (Annual)-158.69%

Gross Margin (Annual)7.64%

Net Profit Margin (5Y Avg)-298.68%

Cash / Share (Quarterly)$1.34

ROA (Last FY)-109.05%

EBITD / Share (TTM)$-2.77

ROE (5Y Avg)-94.13%

Operating Margin (TTM)-500.57%

Cash Flow / Share (Annual)$-2.67

P/B Ratio0.23x

P/B Ratio (Quarterly)1.61x

Net Income / Employee (Annual)$-5,813,600

Net Interest Coverage (TTM)-40.56x

ROA (TTM)-45.39%

EPS Incl Extra (Annual)$-6.72

Current Ratio (Annual)1.40x

Quick Ratio (Quarterly)3.09x

3-Month Avg Trading Volume3.61M

52-Week Price Return-90.21%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$2.33

P/S Ratio (Annual)2.65x

Asset Turnover (Annual)0.21x

52-Week High$8.17

Operating Margin (5Y Avg)-298.11%

EPS Excl Extra (Annual)$-6.72

26-Week Price Return-85.45%

Quick Ratio (Annual)1.27x

13-Week Price Return-84.35%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)3.29x

Enterprise Value$4.10M

Asset Turnover (TTM)0.21x

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)0.00x

Pretax Margin (Annual)-651.36%

Cash / Share (Annual)$2.53

3-Month Return Std Dev291.22%

Gross Margin (5Y Avg)45.57%

Net Income / Employee (TTM)$-7,661,200

ROE (Last FY)-158.69%

Net Interest Coverage (Annual)-4.11x

EPS Basic Excl Extra (Annual)$-6.72

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-3.83

Receivables Turnover (Annual)0.00x

ROI (TTM)-70.59%

P/S Ratio (TTM)5.27x

Pretax Margin (5Y Avg)-301.23%

Revenue / Share (Annual)$0.00

Price vs S&P 500 (52W)-105.75%

Year-to-Date Return-86.51%

5-Day Price Return-7.22%

EPS Normalized (Annual)$-6.72

ROA (5Y Avg)-77.25%

Net Profit Margin (Annual)-651.36%

Month-to-Date Return-36.76%

EBITD / Share (Annual)$-6.56

Operating Margin (Annual)-650.86%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-94.13%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-3.83

P/TBV (Quarterly)1.61x

P/B Ratio (Annual)0.27x

Dividend / Share (TTM)$0.04

Inventory Turnover (TTM)0.00x

Pretax Margin (TTM)-501.52%

Book Value / Share (Annual)$4.38

Price vs S&P 500 (13W)-87.04%

Dividend Yield (TTM)4.33%

Beta2.21x

Revenue / Share (TTM)$0.00

ROE (TTM)-70.59%

52-Week Low$0.42

vGradeB

mGradeF

vgmGradeC

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
QCLSQ/C Technologies, Inc. Common Stock	B	—	F	5.3x	—	24.7%	—	$0.54
IDXXIdexx Laboratories Inc	D	B	B	9.7x	12.8%	62.5%	14.3%	$560.36
LNTHLantheus Holdings, Inc	C	B	B	4.2x	2.4%	61.0%	40.7%	$99.70
NEOGNeogen Corp	C	C	A	2.9x	-0.3%	47.4%	—	$11.81
CLDXCelldex Therapeutics, Inc	F	F	C	13683.0x	-97.3%	17.6%	—	$27.53
NTLAIntellia Therapeutics, Inc	D	D	C	26.9x	12.6%	—	—	$11.42
QDELQuidelOrtho Corporation Common Stock	C	C	C	0.3x	-2.5%	44.6%	—	$12.91
ACHVAchieve Life Sciences, Inc.	F	F	B	36.8x	-89.3%	—	—	$6.38
MYGNMyriad Genetics Inc	C	C	D	0.5x	-3.2%	68.8%	—	$3.98
TKNOAlpha Teknova, Inc. Common Stock	D	C	B	8.7x	12.3%	34.6%	—	$7.08
NNNNAnbio Biotechnology Class A Ordinary Shares	F	C	F	34.0x	-5.7%	89.0%	—	$3.13
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	59.0x	-60.8%	48.3%	—	$3.01
ICCCImmucell Corp	C	C	A	3.2x	8.5%	40.3%	—	$10.75
BMRABIOMERICA INC	B	D	B	1.9x	-16.2%	8.1%	—	$1.85
TRIBTrinity Biotech plc	B	D	C	0.1x	-16.6%	32.9%	—	$8.03
VNRXVolitionRx Limited	B	B	F	2.0x	86.3%	—	—	$0.18
CDIOCardio Diagnostics Holdings Inc. Common stock	—	D	C	345.9x	-25.9%	—	—	$1.69
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	F	156.9x	96.4%	62.0%	—	$1.45
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	F	—	—	—	—	$0.01

About Q/C Technologies, Inc. Common Stock

Q/C Technologies Inc develops blockchain infrastructure using photonic computing technology to improve processing speed and energy efficiency. The company's laser-based processor architecture is designed to address computational limitations in blockchain networks while reducing power consumption. By integrating photonic computing with cryptocurrency systems, Q/C Technologies targets next-generation distributed ledger applications requiring high performance and sustainability.